Malaysia
Search
Sign In
Change Password
Points
Sign Out
Top Medical News
In patients with resistant hypertension, the risk of progression to refractory hypertension is associated with the presence of untreated obstructive sleep apnoea, glycated haemoglobin (HbA1c) concentration, initial heart rate and time since hypertension diagnosis, a study reports.
A retrospective study of Chinese patients in Hong Kong highlights the high misdiagnosis rate of progressive supranuclear palsy (PSP) and identifies important clinical milestones for guiding advanced care planning (ACP) for patients with the condition.
Low levels of physical activity while in the hospital appears to increase the likelihood of hospital-acquired disability (HAD) in elderly adults, a recent study has shown.
Long-term use of solid fuel for cooking and smoking each contribute to an increase in the risk of chronic liver disease mortality, a study suggests.
Significant changes have been observed in the aetiology, management and clinical outcomes in patients with lower gastrointestinal (GI) bleeding over the past 10 years, according to a recent study.
Obesity does not seem to affect 30-day morbidity outcomes in children and adolescents undergoing continent urinary tract reconstruction, a recent study has shown.
Elevated levels of serum high-sensitivity C-reactive protein (hs-CRP) appear to attenuate the response to tadalafil in patients with erectile dysfunction (ED), a recent study has shown.
Special Reports
At a Duopharma-sponsored symposium during the Diabetes Asia Conference 2019 at Hotel Istana, Kuala Lumpur, Professor Dato’ Dr Mafauzy Mohamed spoke about the role of biosimilar insulin glargine in improving access to diabetes treatment, presenting important evidence that affirms the quality, efficacy and safety of the biosimilar product.
Metformin Extended Release 500 mg,750 mg, and 1000 mg
Saxagliptin 5 mg, dapagliflozin 10 mg FC tab
Fenofibrate 145 mg, simvastatin 20 mg FC tab
The latest research, clinical data and innovations in
ophthalmology were presented at the 2019 Annual Meeting of the American Academy
of Ophthalmology (AAO) in San Francisco, USA, held on 12−15 October 2019. As in
previous years, an international panel of renowned ophthalmologists attended
the meeting and contributed articles to Eye on AAO 2019 – an e-Bulletin series featuring
research highlights and hot topics presented at the meeting, with commentaries
on their relevance to clinical practice in the Asia Pacific and Latin American regions.
At a recent Boehringer Ingelheim-sponsored symposium held in conjunction with the 10th Malaysian Endocrine and Metabolic Society Annual Congress, two distinguished speakers spoke on the latest updates in glucose-lowering therapy for the treatment for type 2 diabetes mellitus (T2DM) and highlighted some important cardiovascular outcome trial results of these antidiabetic agents.
At the recent Takeda Malaysia Vocinti® (vonoprazan) launch, held in conjunction with the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2019 at Shangri-La Kuala Lumpur, Professor Akihito spoke about vonoprazan’s merits as an alternative to conventional proton pump inhibitors.
Conference Reports
Twice-a-year injections of the small interfering RNA (siRNA) inclisiran significantly reduced low-density lipoprotein cholesterol (LDL-C) levels in patients with atherosclerotic cardiovascular disease (ASCVD) who have insufficient LDL-C reductions despite maximum oral lipid-lowering therapy, the ORION-10* trial showed.
Circulating miR-155 may be potentially used as a diagnostic and therapeutic monitoring marker in breast cancer, suggests an Indonesian study presented at the 2019 Asia Congress of the European Society for Medical Oncology (ESMO Asia 2019).
Slideshow: Highlights from the ESMO Asia 2019.
First-line treatment with durvalumab + platinum-etoposide (EP)* improves overall survival (OS) in Asian patients with extensive-stage small-cell lung cancer (ES-SCLC), according to the CASPIAN** study.
In breast cancer, especially hormone-negative tumours, an ultrasound-guided core biopsy (CNB) is useful for predicting pathologic complete response (pCR) to chemotherapy and may thus help to avoid surgery for some patients, a study has found.
There appears to be no significant survival difference between first-line immune checkpoint inhibitor (ICI) and carboplatin-based chemotherapy in cisplatin-ineligible metastatic urothelial carcinoma patients, according to a Taiwan study presented at the recent 2019 Asia Congress of the European Society for Medical Oncology (ESMO Asia 2019).
C-reactive protein/albumin ratio (CAR) can provide prognostic information on survival in pancreatic cancer, such that patients with high pretreatment CAR may have poorer overall survival, according to a study presented at the ESMO Asia 2019 Congress.
Multimedia
